Review paper
Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases
Abstract
A better understanding of the immunological processes governed by cytokines and chemokines has shaped our approach to the design of therapeutics for diseases such as rheumatoid arthritis (RA), atherosclerosis, and other inflammatory disorders. The discovery of chemokines and their receptors as integral components and regulators of inflammation has dramatically contributed to advances in treating these disease states. Among the different classes...
Paper Details
Title
Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases
Published Date
Oct 1, 2010
Journal
Volume
10
Issue
5
Pages
263 - 270
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History